BIOMAT Database Logo BIOMAT Database Logo

Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs. 2001

J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada.

OBJECTIVE To determine comparative efficacy of vaccines administered IM and intranasally, used alone or sequentially, to protect puppies from infection with Bordetella bronchiseptica and determine whether systemic or mucosal antibody response correlated with protection. METHODS Randomized controlled trial. METHODS 50 specific-pathogen-free Beagle puppies. METHODS In 2 replicates of 25 dogs each, 14-week-old puppies that were vaccinated against canine distemper virus and parvovirus were vaccinated against B bronchiseptica via intranasal, IM, intranasal-IM, or IM-intranasal administration or were unvaccinated controls. Puppies were challenge exposed via aerosol administration of B bronchiseptica 2 weeks after final vaccination. Clinical variables and systemic and mucosal antibody responses were monitored for 10 days after challenge exposure. Puppies in replicate 1 were necropsied for histologic and immunohistochemical studies. RESULTS Control puppies that were seronegative before challenge exposure developed paroxysmal coughing, signs of depression, anorexia, and fever. Vaccinated puppies (either vaccine) that were seronegative before challenge exposure had fewer clinical signs. Puppies that received both vaccines had the least severe clinical signs and fewest lesions in the respiratory tract. Vaccinated dogs had significantly higher concentrations of B bronchiseptica-reactive antibodies in serum saliva before and after challenge. Antibody concentrations were negatively correlated with bacterial growth in nasal cavity and pharyngeal samples after challenge exposure. CONCLUSIONS Parenterally and intranasally administered vaccines containing B bronchiseptica may provide substantial protection from clinical signs of respiratory tract disease associated with infection by this bacterium. Administration of both types of vaccines in sequence afforded the greatest degree of protection against disease.

UI MeSH Term Description Entries
D007091 Image Processing, Computer-Assisted A technique of inputting two-dimensional or three-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. Biomedical Image Processing,Computer-Assisted Image Processing,Digital Image Processing,Image Analysis, Computer-Assisted,Image Reconstruction,Medical Image Processing,Analysis, Computer-Assisted Image,Computer-Assisted Image Analysis,Computer Assisted Image Analysis,Computer Assisted Image Processing,Computer-Assisted Image Analyses,Image Analyses, Computer-Assisted,Image Analysis, Computer Assisted,Image Processing, Biomedical,Image Processing, Computer Assisted,Image Processing, Digital,Image Processing, Medical,Image Processings, Medical,Image Reconstructions,Medical Image Processings,Processing, Biomedical Image,Processing, Digital Image,Processing, Medical Image,Processings, Digital Image,Processings, Medical Image,Reconstruction, Image,Reconstructions, Image
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D001885 Bordetella Infections Infections with bacteria of the genus BORDETELLA. Infections, Bordetella,Bordetella Infection,Infection, Bordetella
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations

Related Publications

J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Kennel cough: Vaccination against Bordetella bronchiseptica infection.
February 1976, The Veterinary record,
J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine.
July 1978, Research in veterinary science,
J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Experimental Bordetella bronchiseptica infection in guinea pigs.
April 1971, Nihon juigaku zasshi. The Japanese journal of veterinary science,
J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Experimental Bordetella bronchiseptica infection in embryonated eggs.
January 1967, Antimicrobial agents and chemotherapy,
J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Bordetella bronchiseptica infection in cats following contact with infected dogs.
January 2000, The Veterinary record,
J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Experimental infection of Bordetella bronchiseptica to rabbits.
April 1982, Jikken dobutsu. Experimental animals,
J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Immunisation of pigs against experimental infection with Bordetella bronchiseptica.
May 1982, The Veterinary record,
J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Experimental respiratory disease in dogs due to Bordetella bronchiseptica.
January 1976, Research in veterinary science,
J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
[Experimental research with Bordetella bronchiseptica].
September 1958, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale,
J A Ellis, and D M Haines, and K H West, and J H Burr, and A Dayton, and H G Townsend, and E W Kanara, and C Konoby, and A Crichlow, and K Martin, and G Headrick
Bordetella bronchiseptica infection.
November 2017, Medecine et maladies infectieuses,
Copied contents to your clipboard!